Ronald M Cresswell insider trades: Aastrom Biosciences (ASTM) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ronald reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 11, 2011 | ASTM | ↑ Buy | 20,000 | $2.22 | $44K | Direct | Aug 12, 2011 (1d) |
| Mar 24, 2011 | ASTM | ↑ Buy | 20,000 | $2.19 | $44K | Direct | Mar 28, 2011 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Ronald M Cresswell's insider trades
Ronald M Cresswell is a director at Aastrom Biosciences (ASTM). Since Mar 24, 2011, Ronald has reported 2 open-market purchases worth $88K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ASTM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.